Clinical Trial Update: Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of N-acetylcysteine and zinc for managing radiotherapy-induced oral mucositis in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-induced Mucositis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• ZINC (Zinc chloride)

Snippet

Sponsor: Mansoura University | Conditions: Radiation-Induced Mucositis | Phase 2 | Status: COMPLETED